Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 14.03.2025
BioVersys AG
BioVersys AG
/ Key word(s): Annual Results
BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS 14.03.2025 / 07:00 CET/CEST
Basel, Switzerland. March 14, 2025, 7am CET
BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of [ … ]
Fri, 14.03.2025
Matador Secondary Private Equity AG
Ad hoc-Mitteilung gemäss Ziff. 16 Kotierungsreglement der BX Swiss
Matador Secondary Private Equity AG - Annual Report 2024
- Annual profit of CHF 6.3 million at the upper end of expectations
- Net asset value increases by almost 12%
Sarnen, March 14, 2025 - Matador Secondary Private Equity AG generated a profit of CHF 6.3 million [ … ]
Fri, 14.03.2025
Orell Füssli AG
Ad hoc announcement pursuant to Art. 53 LR
Orell Füssli significantly increases Revenue, EBIT and Net income in 2024
Revenue grows by 8.7%, EBIT increases by 24.5%
Increase in net income by 19.6% to CHF 17.5 million.
Successful implementation of strategic projects
Board of Directors proposes to the AGM to increase the dividend to CHF [ … ]
Thu, 13.03.2025
Deutsche Konsum REIT-AG
Publication of inside information in accordance with Art. 17 para. 1 of Regulation (EU) 596/2014 on market abuse (market abuse regulation)
Deutsche Konsum REIT concludes bridge financing agreement Changes in the Supervisory Board
Potsdam, Germany, 13 March 2024 – Deutsche Konsum REIT-AG (the "Company") (ISIN: DE000A14KRD3 | WKN: A14KRD | ticker [ … ]
Thu, 13.03.2025
ABO Energy GmbH & Co. KGaA
ABO Energy GmbH & Co KGaA is expected to close the 2024 financial year with a group net profit of more than EUR 25 million. On 24 November 2024, the company announced in an ad hoc announcement that, according to current planning, a net profit for the year in a range between EUR 20 and 25 million was to be expected. The previous forecast ranged [ … ]
Thu, 13.03.2025
Swiss Prime Site AG
Swiss Prime Site AG
/ Key word(s): AGMEGM
Swiss Prime Site: Annual General Meeting approves all proposals of the Board of Directors with a large majority 13.03.2025 / 18:30 CET/CEST
PRESS RELEASEZug, 13 March 2025
Approval of the annual financial statements 2024 and the distribution of CHF 3.45 per share
Approval of the repor [ … ]
Thu, 13.03.2025
BTQ Technologies Corp.
BTQ Technologies Announces Appointment of Dr. Gavin Brennen as Chief Quantum Officer
Vancouver, March 12, 2025 – BTQ Technologies Corp. (the “Company”) (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks, is pleased to announce the appointment of Dr. Gavin Brennen as Chief [ … ]
Thu, 13.03.2025
HomeToGo SE
HomeToGo to Announce Full Year 2024 Financial Results and 2025 Outlook on 27 March 2025
Luxembourg, 13 March 2025 - HomeToGo SE (Frankfurt Stock Exchange: HTG) will publish its financial results for the full year and fourth quarter of 2024 (ending 31 December 2024) and its outlook for 2025 at 7:00 am CET on 27 March 2025. Dr. Patrick Andrae, Co-fo [ … ]
Thu, 13.03.2025
SHS Gesellschaft für Beteiligungsmanagement mbH
Tuebingen / 13.03.2025
Selfapy GmbH, a digital health pioneer in the field of mental health, has been acquired by MEDICE Health Family, the European market leader in ADHD therapy. As part of the transaction, the investors SHS Capital, Think.Health Ventures, IBB Ventures, and HTGF sold their shares.
Selfapy’s CE-certified medical products p [ … ]
Thu, 13.03.2025
Mainz BioMed N.V.
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood Samples
Mainz Biomed Enters into Exclusive Licensing Agreement for the Portfol [ … ]